NeoGenomics

NeoGenomics is a Florida-based clinical laboratory that provides services including oncology genetic testing, contract research and drug development for physicians.

Business Model:

Revenue: $496.8M

Employees: 1,001-5,000

Detailed NeoGenomics Information

Geographic Data

NeoGenomics headquarters map

Address: 9490 NeoGenomics Way

City: Fort Myers

State: FL

Zip: 33912

Country: US

Financial Info

Stage:

post ipo equity

Raised Last:

$200M

Raised Total:

$151M

Metrics

806,054Website Global Rank

46,819Website Monthly Traffic

Twitter Followers

Description

NeoGenomics is a Florida-based clinical laboratory that provides services including oncology genetic testing, contract research and drug development for physicians.

Contact Phone:
+12397680600

Contact Email:

NeoGenomics went public on 1/14/2000 on the NASDAQ

Listed Exchange:
NASDAQ

IPO Date:
1/14/2000

Ticker Symbol:
NEO

IPO Price:
$5/share

Amount Raised:
$35M

Live

Opened: -/share

EBITDA -
Total Cash -
Total Debt -
Total Revenue -
Total Profit (Gross) -
PE Ratio -
Announced Date Company Transaction Money Raised
5/2020 Inivata Corporate Round 0
5/2020 Inivata Corporate Round 0

Startup Industries

Startup Locations

Portfolio Current Status

Portfolio Employee Count

Uniview Singapore VEID Logo
Uniview Singapore VEID
Revenue: 0 - 100000
Employees:
Industry: Software
Details
Konkuk University Medical Center Logo
Konkuk University Medical Center
Revenue: 0 - 100000
Employees: 51 - 500
Industry: Education
Details
Daemon Technologies Logo
Daemon Technologies
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Blockchain
Details
Ace International Trade Logo
Ace International Trade
Revenue: 0 - 100000
Employees: 11 - 50
Industry: Industrial
Details
An Hòa Communications Logo
An Hòa Communications
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Advertising
Details

You know, we could be doing all this for you..

CoBee's Logo

Be ahead of your competition

  • Realtime intelligence
  • Automated contact tracking
  • Unmatched insights
  • Eliminate manual research